Cross-sectional analysis of cannabis use at work in the USA: differences by occupational risk level and state-level cannabis laws

Objective To examine the prevalence of workplace cannabis use, including by state-level cannabis laws, occupational risk and medical cannabis use.Methods Data are cross-sectional from wave 6 (2023) of the International Cannabis Policy Study (ICPS) and include 26 458 respondents aged 16–65 years from...

Full description

Saved in:
Bibliographic Details
Main Authors: David Hammond, Ava Kucera
Format: Article
Language:English
Published: BMJ Publishing Group 2025-08-01
Series:BMJ Public Health
Online Access:https://bmjpublichealth.bmj.com/content/3/2/e001589.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849340583733100544
author David Hammond
Ava Kucera
author_facet David Hammond
Ava Kucera
author_sort David Hammond
collection DOAJ
description Objective To examine the prevalence of workplace cannabis use, including by state-level cannabis laws, occupational risk and medical cannabis use.Methods Data are cross-sectional from wave 6 (2023) of the International Cannabis Policy Study (ICPS) and include 26 458 respondents aged 16–65 years from the USA. Separate regression models were run analysing workplace cannabis use across: (1) state-level cannabis laws and occupational risk, (2) reasons for cannabis use and (3) medical cannabis authorisation. All models were adjusted for sociodemographic characteristics.Results Overall, 7.4% of workers and 21.5% of past 12-month cannabis consumers reported using cannabis at or within 2 hours of starting work in the last 30 days. Workplace cannabis consumption was highest among workers in states with ‘recreational’ cannabis laws (8.5%) compared with states with medical (6.3%; adjusted OR (AOR)=1.45, p=0.006) or illegal laws (6.2%; AOR=1.06, p=0.005). Workers in high-risk jobs were more likely to use cannabis at work (11.4%) than those in lower risk jobs (5.8%; AOR=1.58, p<0.001). Workplace cannabis use was also greater among cannabis consumers who use cannabis for medical versus recreational (29.4% vs 15.6%; AOR=2.35, p<0.001) or mixed reasons (24.2%; AOR=1.78, p=0.007); the same was true for consumers who reported having medical cannabis authorisation (39.0%) versus those without authorisation (17.4%; AOR=2.66, p<0.001).Conclusions Reported cannabis use at work was most prevalent in states with recreational legalisation, particularly among individuals with medical cannabis authorisation and those who work higher risk jobs. Longitudinal research should examine the individual and occupational-level factors associated with workplace cannabis use.
format Article
id doaj-art-20d77082ce834040bb0813a675d9ca9e
institution Kabale University
issn 2753-4294
language English
publishDate 2025-08-01
publisher BMJ Publishing Group
record_format Article
series BMJ Public Health
spelling doaj-art-20d77082ce834040bb0813a675d9ca9e2025-08-20T03:43:52ZengBMJ Publishing GroupBMJ Public Health2753-42942025-08-013210.1136/bmjph-2024-001589Cross-sectional analysis of cannabis use at work in the USA: differences by occupational risk level and state-level cannabis lawsDavid Hammond0Ava Kucera14 School of Public Health Sciences, University of Waterloo, Waterloo, Ontario, CanadaSchool of Public Health Sciences, University of Waterloo, Waterloo, Ontario, CanadaObjective To examine the prevalence of workplace cannabis use, including by state-level cannabis laws, occupational risk and medical cannabis use.Methods Data are cross-sectional from wave 6 (2023) of the International Cannabis Policy Study (ICPS) and include 26 458 respondents aged 16–65 years from the USA. Separate regression models were run analysing workplace cannabis use across: (1) state-level cannabis laws and occupational risk, (2) reasons for cannabis use and (3) medical cannabis authorisation. All models were adjusted for sociodemographic characteristics.Results Overall, 7.4% of workers and 21.5% of past 12-month cannabis consumers reported using cannabis at or within 2 hours of starting work in the last 30 days. Workplace cannabis consumption was highest among workers in states with ‘recreational’ cannabis laws (8.5%) compared with states with medical (6.3%; adjusted OR (AOR)=1.45, p=0.006) or illegal laws (6.2%; AOR=1.06, p=0.005). Workers in high-risk jobs were more likely to use cannabis at work (11.4%) than those in lower risk jobs (5.8%; AOR=1.58, p<0.001). Workplace cannabis use was also greater among cannabis consumers who use cannabis for medical versus recreational (29.4% vs 15.6%; AOR=2.35, p<0.001) or mixed reasons (24.2%; AOR=1.78, p=0.007); the same was true for consumers who reported having medical cannabis authorisation (39.0%) versus those without authorisation (17.4%; AOR=2.66, p<0.001).Conclusions Reported cannabis use at work was most prevalent in states with recreational legalisation, particularly among individuals with medical cannabis authorisation and those who work higher risk jobs. Longitudinal research should examine the individual and occupational-level factors associated with workplace cannabis use.https://bmjpublichealth.bmj.com/content/3/2/e001589.full
spellingShingle David Hammond
Ava Kucera
Cross-sectional analysis of cannabis use at work in the USA: differences by occupational risk level and state-level cannabis laws
BMJ Public Health
title Cross-sectional analysis of cannabis use at work in the USA: differences by occupational risk level and state-level cannabis laws
title_full Cross-sectional analysis of cannabis use at work in the USA: differences by occupational risk level and state-level cannabis laws
title_fullStr Cross-sectional analysis of cannabis use at work in the USA: differences by occupational risk level and state-level cannabis laws
title_full_unstemmed Cross-sectional analysis of cannabis use at work in the USA: differences by occupational risk level and state-level cannabis laws
title_short Cross-sectional analysis of cannabis use at work in the USA: differences by occupational risk level and state-level cannabis laws
title_sort cross sectional analysis of cannabis use at work in the usa differences by occupational risk level and state level cannabis laws
url https://bmjpublichealth.bmj.com/content/3/2/e001589.full
work_keys_str_mv AT davidhammond crosssectionalanalysisofcannabisuseatworkintheusadifferencesbyoccupationalrisklevelandstatelevelcannabislaws
AT avakucera crosssectionalanalysisofcannabisuseatworkintheusadifferencesbyoccupationalrisklevelandstatelevelcannabislaws